{"id":16719,"date":"2020-08-26T07:56:11","date_gmt":"2020-08-26T11:56:11","guid":{"rendered":"https:\/\/medicarereport.org\/?p=16719"},"modified":"2020-08-26T08:02:36","modified_gmt":"2020-08-26T12:02:36","slug":"10-most-expensive-drugs-in-the-us","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=16719","title":{"rendered":"10 most expensive drugs in the US"},"content":{"rendered":"<p>(By Katie Adams for <em>Becker&#8217;s Hospital Review<\/em>)<\/p>\n<p>Spinal muscular atrophy treatment Zolgensma&#8217;s annual price tag of $2,125,000 makes it the most expensive drug in the U.S., according to a list recently published by online drug price comparison platform GoodRx.\u00a0 Continue reading article <a href=\"https:\/\/www.beckershospitalreview.com\/pharmacy\/10-most-expensive-drugs-in-the-us.html\">here&#8230;<\/a><\/p>\n<p><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2018\/04\/dreamstime_m_36312255pills-medicine-dollar-cost.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-10021\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2018\/04\/dreamstime_m_36312255pills-medicine-dollar-cost-300x200.jpg\" alt=\"\" width=\"300\" height=\"200\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2018\/04\/dreamstime_m_36312255pills-medicine-dollar-cost-300x200.jpg 300w, https:\/\/medicarereport.org\/wp-content\/uploads\/2018\/04\/dreamstime_m_36312255pills-medicine-dollar-cost-768x512.jpg 768w, https:\/\/medicarereport.org\/wp-content\/uploads\/2018\/04\/dreamstime_m_36312255pills-medicine-dollar-cost-1024x683.jpg 1024w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<pre><strong>Notice:<\/strong> The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org<\/pre>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>(By Katie Adams for Becker&#8217;s Hospital Review) Spinal muscular atrophy treatment Zolgensma&#8217;s annual price tag of $2,125,000 makes it the<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[21,15],"tags":[],"class_list":["post-16719","post","type-post","status-publish","format-standard","hentry","category-health-care-finance","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/16719","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=16719"}],"version-history":[{"count":2,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/16719\/revisions"}],"predecessor-version":[{"id":16721,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/16719\/revisions\/16721"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=16719"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=16719"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=16719"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}